One in three young people in foster care reports using alcohol, cannabis, or tobacco. That figure is nearly double the national rate for adolescents. Researchers are now drawing attention to foster care substance use screening as a practical, low-burden tool that healthcare providers can deliver in under 15 minutes, with measurable results. Two new studies suggest the approach works, at least in the short term.

The Scale of the Problem

More than 500,000 children and young people are in foster care across the United States. They already face disproportionate exposure to trauma, instability, and family disruption. This group carries a significantly higher risk of early substance use. Yet effective, scalable prevention has been hard to achieve.

The first study, led by Dr Mary Greiner at Cincinnati Children’s Hospital Medical Center, screened 373 young people using a tablet-based questionnaire called the CRAFFT. It assesses past-year use of alcohol, cannabis, tobacco, and other substances. The results were striking. Among those screened, 34 per cent reported some form of substance use. That compares to around 21.6 per cent in the general adolescent population. Cannabis was the most commonly reported substance, with nearly 21 per cent of participants endorsing use. When researchers added a nicotine question to the tool in late 2022, a further 15 per cent of young people reported tobacco or vaping use. Of those, 80 per cent were also using at least one other substance.

When Foster Care Substance Use Screening Falls Short

The research uncovered a troubling gap. Around 12 per cent of young people who initially returned a negative screen later disclosed substance use during a private conversation with a healthcare provider. Those young people were, on average, two years older than those who reported accurately on the questionnaire. They were also far more likely to live in independent living placements than in traditional foster or kinship homes.

Researchers suggest this pattern of under-reporting may stem from confidentiality concerns, literacy challenges, or the vulnerabilities specific to young people navigating independent living with little adult oversight. Whatever the cause, it represents a meaningful missed opportunity for early intervention.

The findings confirm what many specialists already suspected. Digital screening alone is not enough. Healthcare providers need to follow up negative screens with a brief private conversation, particularly with older adolescents.

What Happens After a Brief Intervention

The second study followed 287 young people over six months. Each received a brief negotiated interview on the same day as their screening. This is a structured, motivational conversation lasting between five and fifteen minutes. A trained interventionist delivers it as part of the routine clinic visit.

At baseline, cannabis use was the most prevalent. Some 45 per cent of participants reported use in the previous 30 days. Alcohol use stood at around 21 per cent, and tobacco or nicotine products at 26 per cent. Both figures sit higher than national survey averages for adolescents of similar ages.

Results at 30 and 60 days post-intervention were encouraging. Average days of cannabis use in the past 30 days fell from 4.83 at baseline to 3.04 at the 30-day mark. Tobacco and nicotine use dropped from an average of 4.32 days per month to 2.70. Alcohol use fell further still. By 30 days, 92 per cent of participants reported zero days of use, up from 84 per cent at baseline.

Promising Early Results, but Effects Fade

By the six-month point, the picture had changed. Use of all three substances rebounded close to baseline levels. The study authors are candid about what this means. A single brief intervention, however well delivered, cannot sustain behaviour change without reinforcement.

“The benefits of SBIRT are observed in the first 60 days following intervention,” the authors note. “Repeat brief intervention after 60 days may be especially important for those who continue to use substances, and for older adolescents.”

This finding sits within a wider context for foster care youth substance use prevention. Existing programmes designed for this population, including adaptations of Guiding Good Choices and Treatment Foster Care Oregon, require intensive delivery over many weeks or months. They also typically need the involvement of foster carers or kinship caregivers. A recent meta-analysis found no evidence these models effectively prevent or reduce substance use in young people in care. SBIRT requires no caregiver involvement. It fits inside a routine medical appointment. That makes it a genuinely different kind of option.

Substance Use Screening in Foster Care: Who Faces the Greatest Risk

The research identified several factors linked to a return to use at the six-month mark. Young people in independent living placements were significantly more likely to report alcohol and cannabis use at 180 days. Older adolescents were more likely to resume tobacco and cannabis use. Having multiple mental health diagnoses was associated with a higher likelihood of alcohol use in the months following intervention.

Placement changes, which are common for young people in care, were also linked to increased tobacco use at six months. Parental substance use history showed an unexpected association with lower rates of cannabis use at six months. The authors acknowledge the complexity of interpreting this without further data.

What the Evidence Means for Practice

The two studies together build a picture that is both hopeful and clear-eyed. Foster care substance use screening is feasible, acceptable to young people, and capable of generating meaningful short-term reductions in use. That matters enormously in a population where effective and accessible prevention has been in short supply.

The research also highlights the limits of a single clinical encounter. The authors call for a combined approach, pairing SBIRT with sustained follow-up and, where appropriate, referral to longer-term support. For healthcare systems seeking scalable options, this could mean repeat brief intervention at subsequent appointments. It could also mean better links to community-based services that build on what the clinic starts.

“Substance use was significantly reduced in the 60 days following universal delivery of SBIRT,” the authors conclude. “Additional intervention is needed to sustain long-term reductions in use.”

For the hundreds of thousands of young people in care across the UK and beyond, and for the practitioners who work with them, the message is plain. Early, consistent, and confidential support makes a difference. Getting it right could change a young person’s direction entirely.

Source: dbrecoveryresources